Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 573-579

  Guo, Jun ^a   Shi, Lei ^b   Li, Min ^c   Xu, Jin ^a   Yan, Shushan ^d   Zhang, Chuang ^d   Sun, Guan ^a  

^a NANTONG UNIVERSITY   (China)

^b KUNSHAN FIRST PEOPLE S HOSPITAL AFFILIATED TO JIANGSU UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d PLA Cancer Center in Eighty One Hospital of People's Liberation Army   (China)

Author keywords

Glioma; Interleukin 4R ; Meta analysis; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 4 RECEPTOR ALPHA;

ARTICLE; ASIAN; BRAIN TUMOR; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONFIDENCE INTERVAL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GLIOMA; HUMAN; IMMUNOREGULATION; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENOTYPE; GLIOMA; HUMANS; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84894467044     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1080-9     Document Type: Article

References (33)

1. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology andmolecular pathology of glioma. Nat Clin Pract Neurol. 2006;2:494- 503. Quiz 1 p following 16.
2. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93-108.
3. Ohgaki H. Epidemiology of brain tumors. Methods Mol Biol. 2009;472:323-42.
4. Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, et al. Allergic conditions and brain tumor risk. Am J Epidemiol. 2007;166:941-50.
5. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, van TongerenM,Muir KR, McKinney PA. History of allergic disease and risk of meningioma. Am J Epidemiol. 2007;165:477-85.
6. Berg-Beckhoff G, Schuz J, Blettner M, Munster E, Schlaefer K, Wahrendorf J, et al. History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany). Eur J Epidemiol. 2009;24:433-40.
7. Amirian E, Liu Y, Scheurer ME, El-Zein R, GilbertMR, Bondy ML. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol. 2010;12:444-52.
8. Jin T, Li X, Zhang J,Wang H, Geng T, Li G, et al. Genetic association between selected cytokine genes and glioblastoma in the Han Chinese population. BMC Cancer. 2013;13:236.
9. Llanes E, Quiralte J, Lopez E, Sastre B, Chacartegui M, del Pozo V, et al.Analysis of polymorphisms in olive pollen allergy: IL13, IL4RA, IL5 and ADRB2 genes. IntArchAllergy Immunol. 2009;148:228-38.
10. Howard TD, Koppelman GH, Xu J, Zheng SL, Postma DS, Meyers DA, et al. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet. 2002;70:230-6.
11. Liu X, Beaty TH, Deindl P, Huang SK, Lau S, Sommerfeld C, et al. Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immunol. 2004;113:489-95.
12. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256-66.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
14. Mantel N, HaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
15. DerSimonian R, LairdN.Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test.BMJ. 1997;315:629-34.
17. Stuck AE, Rubenstein LZ,WielandD. Bias inmeta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. Author reply 70-1.
18. Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev. 2007;16:1229-35.
19. Schwartzbaum JA, Ahlbom A, Lonn S,Malmer B,Wigertz A, Auvinen A, et al. An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev. 2007;16:2448-54.
20. Ruan Z, Zhao Y, Yan L, Chen H, Fan W, Chen J, et al. Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma. Front Biosci (Elite Ed). 2011;3:33-45.
21. Li S, Jin T, Zhang J, Lou H, Yang B, Li Y, et al. Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma. Cancer Epidemiol. 2012;36:283-7.
22. Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol. 1998;17:1-52.
23. Heller NM, Gwinn WM, Donnelly RP, Constant SL, Keegan AD. IL- 4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro. PLoS One. 2012;7:e39673.
24. Andrews AL, Holloway JW, Holgate ST, Davies DE. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol. 2006;176:7456-61.
25. Hosoyama T, Aslam MI, Abraham J, Prajapati SI, Nishijo K, Michalek JE, et al. IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma. Clin Cancer Res. 2011;17:2757-66.
26. Johnson LG, Schwartz SM, Malkki M, Du Q, Petersdorf EW, Galloway DA, et al. Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol Biomarkers Prev. 2011;20:199-207.
27. Turner MC. Epidemiology: allergy history, IgE, and cancer. Cancer Immunol Immunother. 2012;61:1493-510.
28. Olson SH, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, et al. Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev. 2007;31:345-51.
29. Curran CS, Bertics PJ. Eosinophils in glioblastoma biology. J Neuroinflammation. 2012;9:11.
30. Backes DM, Siddiq A, Cox DG, Calboli FC, Gaziano JM,Ma J, et al. Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol. 2013;113:229-38.
31. Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst. 2012;104:1251-9.
32. Calboli FC, Cox DG, Buring JE, Gaziano JM, Ma J, Stampfer M, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011;103:1588-95.
33. Sun G, Wang X, Shi L, Yue X, Fu L, Chen C, et al. Association between polymorphisms in interleukin-4Ralpha and interleukin-13 and glioma risk: a meta-analysis. Cancer Epidemiol. 2013;37:306-10.